Bing‐ling Peng

593 total citations
11 papers, 402 citations indexed

About

Bing‐ling Peng is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Bing‐ling Peng has authored 11 papers receiving a total of 402 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 2 papers in Cancer Research and 1 paper in Oncology. Recurrent topics in Bing‐ling Peng's work include Cancer-related gene regulation (9 papers), Epigenetics and DNA Methylation (6 papers) and Protein Degradation and Inhibitors (3 papers). Bing‐ling Peng is often cited by papers focused on Cancer-related gene regulation (9 papers), Epigenetics and DNA Methylation (6 papers) and Protein Degradation and Inhibitors (3 papers). Bing‐ling Peng collaborates with scholars based in China and United States. Bing‐ling Peng's co-authors include Wen Liu, Yaohui He, Haifeng Shen, Xiang Gao, Wenjuan Li, Mingfeng Huang, Ting Ran, Rong-quan Xiao, Wenjuan Zhang and Michael G. Rosenfeld and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Nature Communications.

In The Last Decade

Bing‐ling Peng

10 papers receiving 399 citations

Peers

Bing‐ling Peng

ONCOL

PRM

IMMUN

Peter J. Mullen Canada

Sen-Hao Xiao China

Dong‐In Koh South Korea

Jingying Cao China

Andreana Holowatyj United States

Glauber C. Brito Brazil

Sang Wu Lee South Korea

Cynthia Metierre Australia

Shunsheng Zheng China

Peter J. Mullen Canada

Bing‐ling Peng

228 ×0.6

88 ×1.5

37 ×0.9

ONCOL

20 ×0.9

PRM

19 ×0.8

IMMUN

Citations per year, relative to Bing‐ling Peng Bing‐ling Peng (= 1×) peers Peter J. Mullen

Countries citing papers authored by Bing‐ling Peng

Since Specialization

Citations

This map shows the geographic impact of Bing‐ling Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bing‐ling Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bing‐ling Peng more than expected).

Fields of papers citing papers by Bing‐ling Peng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bing‐ling Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bing‐ling Peng. The network helps show where Bing‐ling Peng may publish in the future.

Co-authorship network of co-authors of Bing‐ling Peng

This figure shows the co-authorship network connecting the top 25 collaborators of Bing‐ling Peng. A scholar is included among the top collaborators of Bing‐ling Peng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bing‐ling Peng. Bing‐ling Peng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Chen, Lu, Guo-Sheng Hu, Bing‐ling Peng, et al.. (2025). Nuclear receptor ESRRA promotes ERα-positive breast cancer through dual action on super enhancers and promoters to regulate gene transcriptional programs. Science Bulletin. 70(22). 3822–3839.

Huang, Mingfeng, Yaohui He, Wenjuan Zhang, et al.. (2024). CARM1 hypermethylates the NuRD chromatin remodeling complex to promote cell cycle gene expression and breast cancer development. Nucleic Acids Research. 52(12). 6811–6829. 2 indexed citations

Peng, Bing‐ling, Ting Ran, Xue Chen, et al.. (2024). A CARM1 Inhibitor Potently Suppresses Breast Cancer Both In Vitro and In Vivo. Journal of Medicinal Chemistry. 67(10). 7921–7934. 4 indexed citations

Li, Wenjuan, Yaohui He, Jingjing Yang, et al.. (2021). Profiling PRMT methylome reveals roles of hnRNPA1 arginine methylation in RNA splicing and cell growth. Nature Communications. 12(1). 1946–1946. 123 indexed citations

Shen, Haifeng, Wenjuan Zhang, Ying Huang, et al.. (2021). The Dual Function of KDM5C in Both Gene Transcriptional Activation and Repression Promotes Breast Cancer Cell Growth and Tumorigenesis. Advanced Science. 8(9). 2004635–2004635. 38 indexed citations

Peng, Bing‐ling, Wenjuan Li, Jian‐cheng Ding, et al.. (2020). A hypermethylation strategy utilized by enhancer-bound CARM1 to promote estrogen receptor α-dependent transcriptional activation and breast carcinogenesis. Theranostics. 10(8). 3451–3473. 43 indexed citations

Ran, Ting, Wenjuan Li, Bing‐ling Peng, et al.. (2019). Virtual Screening with a Structure-Based Pharmacophore Model to Identify Small-Molecule Inhibitors of CARM1. Journal of Chemical Information and Modeling. 59(1). 522–534. 13 indexed citations

Gao, Weiwei, Rong-quan Xiao, Wenjuan Zhang, et al.. (2018). JMJD6 Licenses ERα-Dependent Enhancer and Coding Gene Activation by Modulating the Recruitment of the CARM1/MED12 Co-activator Complex. Molecular Cell. 70(2). 340–357.e8. 68 indexed citations

Zhang, Wenjuan, Xiaonan Wu, Yi Jia, et al.. (2016). Regulation of Transcription Factor Yin Yang 1 by SET7/9-mediated Lysine Methylation. Scientific Reports. 6(1). 38 indexed citations

10.

Gao, Weiwei, Rong-quan Xiao, Bing‐ling Peng, et al.. (2015). Arginine methylation of HSP70 regulates retinoid acid-mediated RARβ2 gene activation. Proceedings of the National Academy of Sciences. 112(26). E3327–36. 61 indexed citations

11.

Janusz, Michael J., Kimberly K. Brown, Lily C. Hsieh, et al.. (2006). Comparison of the pharmacology of hydroxamate- and carboxylate-based matrix metalloproteinase inhibitors (MMPIs) for the treatment of osteoarthritis. Inflammation Research. 55(2). 60–65. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact